Health Promotion and Management for Hepatitis B Carriers
This trial is active, not recruiting.
|Condition||chronic hepatitis b|
|Treatment||standardized exercise program and dietary counseling|
|Sponsor||National Taiwan University Hospital|
|Collaborator||National Taiwan University|
|Start date||August 2009|
|End date||July 2010|
|Trial size||160 participants|
|Trial identifier||NCT01065363, 200906036R|
The investigators propose a project of preventive medicine with concern of local context in Taiwan. The target population includes all staff and faculty members, students, and alumni of a university in Northern Taiwan, with chronic hepatitis B infection. The intervention of this project includes standardized lectures, sports courses, nutrition courses, and an information platform. The investigators will evaluate the efficacy after the intervention, like the reduction of hepatitis B viral load and the associated anthropometric parameters. The results of this project will be initially served as a pilot study for this cohort, and applicated as a promising basis for health promotion.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
Reduction of relative serum HBV DNA levels
time frame: three months
time frame: three months
Male or female participants at least 18 years old.
Inclusion Criteria: - Participants were recruited from students, alumni, faculty and staff members with chronic HBV infection (positive HBsAg serostatus ≥6 months) in a university of northern Taiwan from August 1, 2009 to July 01, 2010. Only participants aged 18 and older were included. Exclusion Criteria: - Excluded were: - (a) those who had been diagnosed as chronic liver diseases like chronic hepatitis C infection (Anti-HCV (+)), autoimmune hepatitis, Wilson disease, alcoholic liver diseases, drug-related hepatitis, decompensated liver diseases, cirrhosis, or malignant hepatic tumors; - (b) those who had undergone liver transplantation or major operations for liver except cholecystectomy; - (c) men who consumed more than 30 gram of alcohol per week or women who consumed more than 20 gram of alcohol per week; - (d) women who were pregnant; - (e) those who had current medications for any types of chronic diseases except for hyperglycemia, elevated blood pressure, or dyslipidemia within six months.
|Official title||Project of Health Promotion and Management for Hepatitis B Carriers in NTU Campus|
|Principal investigator||Jin-Shin Lai, MD|
Call for more information